International study for treatment of relapsed high risk childhood ALL (HR-ALL)

  • Strong, Robyn, (Project Manager)
  • Revesz, Tamas (Primary Chief Investigator (PCI))
  • Sutton, Rosemary (Chief Investigator (CI))
  • Lock, Richard B (Chief Investigator (CI))
  • Trahair, Toby (Chief Investigator (CI))
  • Dalla Pozza, Luciano (Chief Investigator (CI))
  • Downie, Peter (Chief Investigator (CI))
  • Osborn, Michael (Chief Investigator (CI))
  • Jones, Janelle, (Chief Investigator (CI))

Project: Research

Project Description

Randomised Phase II trial to improve the outcomes of children and adolescents diagnosed with ALL with a high risk first relapse by determining if the addition of a new therapeutic agent (Bortezomib) to the standard chemotherapy treatment protocol (ALL-R3) will improve rates of subsequent relapses and provide effective disease control in children with HR-ALL.
Short titleIntReALL HR
AcronymIntReALL HR
StatusActive
Effective start/end date1/10/1830/03/22

Funding

  • The Kids' Cancer Project: AUD416,422.00